Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics
APEN Price/Volume Stats
| Current price | $10.00 | 52-week high | $10.30 |
| Prev. close | $9.92 | 52-week low | $3.49 |
| Day low | $9.92 | Volume | 1,658,800 |
| Day high | $10.00 | Avg. volume | 1,432,125 |
| 50-day MA | $9.91 | Dividend yield | N/A |
| 200-day MA | $7.43 | Market Cap | 579.72M |
APEN Stock Price Chart Interactive Chart >
Apollo Endosurgery, Inc. (APEN) Company Bio
Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.
APEN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
APEN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 122.22% |
| 5-year | 449.45% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | 18.27% |
| 2021 | 147.94% |
| 2020 | 19.30% |